A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.

Por Adachi, I., Watanabe, T., Takashima, S., Narabayashi, M., Horikoshi, N., Aoyama, H., Taguchi, T.
Publicado em 1996

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer

Por Katakami, N, Harada, T, Murata, T, Shinozaki, K, Tsutsumi, M, Yokota, T, Arai, M, Tada, Y, Narabayashi, M, Boku, N
Publicado no Ann Oncol (2018)

Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction

Por Masunaga, S, Sakurai, Y, Tanaka, H, Hirayama, R, Matsumoto, Y, Uzawa, A, Suzuki, M, Kondo, N, Narabayashi, M, Maruhashi, A, Ono, K
Publicado em 2013

A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.

Por Ando, M., Watanabe, T., Sasaki, Y., Ying, D. F., Omuro, Y., Katsumata, N., Narabayashi, M., Tokue, Y., Fujii, H., Igarashi, T., Wakita, H., Ohtsu, T., Itoh, K., Adachi, I., Taguchi, T.
Publicado em 1998

Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy

Por Akiyama, Y., Fujita, K., Nagashima, F., Yamamoto, W., Endo, H., Sunakawa, Y., Yamashita, K., Ishida, H., Mizuno, K., Araki, K., Ichikawa, W., Miya, T., Narabayashi, M., Kawara, K., Sugiyama, M., Hirose, T., Ando, Y., Sasaki, Y.
Publicado em 2008